Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide

Abstract

Low doses of arsenic trioxide can induce complete remissions in patients with APL who have relapsed. The clinical response is associated with incomplete cytodifferentiation and the induction of apoptosis with caspase activation in leukemic cells.